Back to results
Not yet recruitingN/A

Marker of Brain Insulin Resistance in AD Prognosis

NCT06825663

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Contact

Catherine Malaplate, PhD,PharmD

00 33 (0)3 83 15 55 13c.malaplate@chru-nancy.fr
View on ClinicalTrials.gov
Marker of Brain Insulin Resistance in AD Prognosis — TrialFind